Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: STOP Heart Disease in Breast Cancer Survivors Trial [Phase 2]
A Phase 2 trial investigating strategies to prevent or mitigate cardiotoxicity in breast cancer survivors; the study is terminated with resu…
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery [NA]
A completed clinical trial evaluating the use of supine MRI images in breast conserving surgery for breast cancer, with results posted in 20…
-
EMA research · 2019-04-30Re-analysis of data on use of breast cancer medicine Tyverb following treatment with trastuzumab
EMA re-analyzed data on using Tyverb (lapatinib) after trastuzumab treatment for breast cancer to clarify outcomes and potential implication…
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers [NA]
A completed clinical trial assessing the accuracy of a Breast Cancer Locator (BCL) in patients with palpable breast cancers has posted resul…
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction [NA]
A completed clinical trial assessing the use of bioprosthetic mesh to expand the lower pole in tissue expander reconstruction for breast can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer [Phase 3]
Phase 3 trial update for Endocrine Against Locoregional Therapy in postmenopausal women with operable breast cancer; trial status terminated…
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: 18F-NaF PET Imaging for Bone Scintigraphy [Phase 3]
Phase 3 trial update on 18F-NaF PET imaging for bone scintigraphy in patients with bone metastases from breast or prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Calcitriol, Physical Activity, and Bone Health in Cancer Survivors [Phase 2]
Phase 2 trial investigating calcitriol with physical activity for bone health in cancer survivors, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial update investigating pyrotinib combined with metronomic capecitabine in HER2-positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer [Phase 2]
Phase II trial evaluating pyrotinib combined with etoposide for HER2-positive advanced breast cancer is in Phase II with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: Vitamin D and Breast Cancer: Does Weight Make a Difference? [Phase 2]
Phase 2 trial evaluated whether vitamin D supplementation influences outcomes in breast cancer and whether patient weight affects the relati…
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study [Phase 2]
Exploratory Phase 2 study evaluating pyrotinib in combination with nab-paclitaxel for HER2-positive advanced breast cancer.
-
FDA approval · 2019-04-17FDA Approved: OGIVRI — Supplemental Application (Biocon Biologics Inc.)
The FDA approved Biocon Biologics' supplemental application for OGIVRI (trastuzumab-dkst), a trastuzumab biosimilar.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating vinorelbine with trastuzumab emtansine in pre-treated HER2-positive metastatic breast cancer has been …
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions [Phase 3]
Phase 3 trial update on zoledronic acid in metastatic breast cancer patients with non-symptomatic bone lesions; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial of PANVAC-V and PANVAC-F vaccines with sargramostim in advanced cancers (adenocarcinoma, colorectal cancer; other listed con…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer [Phase 2]
This entry reports results from a Phase 2 trial evaluating neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer. The result…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC [Phase 2]
A Phase 2 trial evaluating pyrotinib in combination with trastuzumab and AI for first-line treatment of HER2-positive, hormone receptor-posi…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients [Phase 4]
Phase 4 clinical trial update assessing efficacy and safety of neoadjuvant DC-T in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer [NA]
Clinical trial update for contrast-enhanced digital mammography in women with newly diagnosed breast cancer; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer [Phase 3]
Phase 3 Clinical Study of UTD1 Injection combined with Capecitabine in advanced/metastatic breast cancer has completed.
-
FDA approval · 2019-04-08FDA Approved: SOLTAMOX — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for Soltamox (tamoxifen citrate) submitted by Mayne Pharma.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC [Phase 2]
Phase 2 trial evaluating palbociclib with exemestane and GnRH versus capecitabine in premenopausal women with HR+ metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) [Phase 2]
Phase 2 trial evaluating Kadcyla (trastuzumab emtansine) plus capecitabine in HER2-positive metastatic breast cancer or HER2-positive locall…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer [Phase 2]
Phase 2 trial update of Endostar in combination with chemotherapy for HER-2 negative advanced breast cancer.